# Mapi Pharma to build sterile injectable production plant in Jerusalem

Mapi Pharma signed a long-term lease at Har-Hotzvim Hi-Tech Park in Jerusalem for a new sterile production plant for GA Depot injectable products. The ~50,000 sq ft facility was previously an FDA-approved facility of Omrix Biopharmaceuticals. Investment in equipment is approximately $13 million, partially funded by a $2.5 million grant.

- Type: New facility
- Announced: 2019-07-15
- Where: Jerusalem, Israel, Israel
- Value: $13.0M
- Status: announced
- Products: sterile injectable products, GA Depot
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Mapi Pharma Ltd.](https://endata.com/companies/40642.md)

## Sources

- [einpresswire.com](https://www.einpresswire.com/article/490687718/mapi-pharma-to-build-a-new-sterile-injectable-production-plant-for-ga-depot-in-jerusalem), 2019-07-15: "Mapi Pharma Ltd., a fully integrated, late-stage clinical development biopharmaceutical company announced today that is has signed a long term lease agreement at the Har-Hotzvim Hi-Tech Park in Jerusalem for the establishment of a new sterile production plant for GA Depot injectable products."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.